What does this rFVIIa treatment mean for you?

NovoSeven® RT means speed, effectiveness and portability. It’s a recombinant bypassing agent that you infuse on-demand, and has a long history of helping people control their bleeds.

Take a Closer Look

What does this rFVIIa treatment mean for you?

NovoSeven® RT means speed, effectiveness and portability. It’s a recombinant bypassing agent that you infuse on-demand, and has a long history of helping people control their bleeds.

Take a Closer Look

NovoSeven® RT is used to treat more types of bleeding disorders than any other factor product.

Syringe and vials of NovoSeven® RT (Coagulation Factor VIIa [Recombinant])

What is the safety profile of NovoSeven® RT?

NovoSeven® RT is engineered for recombinant safety. It is manufactured to minimize the possibility of viral contamination, and undergoes an extensive 5-step purification process. And studies show NovoSeven® RT has a low rate of thrombotic adverse events (blood clots).a

The most common and serious side effects are blood clots.

View safety information

aIn people with hemophilia A or B with inhibitors.

Male and Female standing

Who uses NovoSeven® RT?

People who use NovoSeven® RT are talking about fast infusion time, and portability makes it possible to take their treatment along when they’re on the go. You may find that their experiences are similar to yours.

Hear their stories

What is the safety profile of NovoSeven® RT?

NovoSeven® RT is engineered for recombinant safety. It is manufactured to minimize the possibility of viral contamination, and undergoes an extensive 5-step purification process. And studies show NovoSeven® RT has a low rate of thrombotic adverse events (blood clots).a

The most common and serious side effects are blood clots.

View safety information

aIn people with hemophilia A or B with inhibitors.

Who uses NovoSeven® RT?

People who use NovoSeven® RT are talking about fast infusion time, and portability makes it possible to take their treatment along when they’re on the go. You may find that their experiences are similar to yours.

Hear their stories

New to NovoSeven® RT?

Here’s how to get started:

New to NovoSeven® RT? Here’s how to get started:

I have just been prescribed NovoSeven® RT.

Let’s Get Started

I am considering NovoSeven® RT.

Learn About Options

Selected Important Safety Information

WARNING: BLOOD CLOTS

  • Serious blood clots that form in veins and arteries with the use of NovoSeven® RT have been reported.
  • Your healthcare provider should discuss the risks and explain the signs and symptoms of blood clots to you. Some signs of a blood clot may include pain, swelling, warmth, redness, or a lump in your legs or arms, chest pain, shortness of breath, or sudden severe headache and/or loss of consciousness or function.
  • Your healthcare provider should monitor you for blood clots during treatment with NovoSeven® RT.

Indications and Usage

NovoSeven® RT (Coagulation Factor VIIa [Recombinant]) is used for:

  • Treatment of bleeding and prevention of bleeding for surgeries and procedures in adults and children with hemophilia A or B with inhibitors, congenital Factor VII (FVII) deficiency, and people with Glanzmann’s thrombasthenia who have a decreased or absent response to platelet transfusions
  • Treatment of bleeding and prevention of bleeding for surgeries and procedures in adults with acquired hemophilia

Important Safety Information

WARNING: BLOOD CLOTS

  • Serious blood clots that form in veins and arteries with the use of NovoSeven® RT have been reported.
  • Your healthcare provider should discuss the risks and explain the signs and symptoms of blood clots to you. Some signs of a blood clot may include pain, swelling, warmth, redness, or a lump in your legs or arms, chest pain, shortness of breath, or sudden severe headache and/or loss of consciousness or function.
  • Your healthcare provider should monitor you for blood clots during treatment with NovoSeven® RT.

Warnings and Precautions

  • NovoSeven® RT should be used with caution if you have an increased risk for blood clots, such as with disseminated intravascular coagulation (DIC), clogged arteries, crush injury, septicemia (an infection in the blood), uncontrolled bleeding after giving birth, history of heart disease, liver disease, limited movement following surgery, in elderly people, in newborns, or if you are taking aPCCs/PCCs (activated or nonactivated prothrombin complex concentrates) with NovoSeven® RT.
  • Allergic reactions, including serious whole body allergic reactions, have been reported with NovoSeven® RT. Tell your healthcare provider if you are allergic to NovoSeven® RT, any of its ingredients, or mice, hamsters, or cows. If you think you are having an allergic reaction, call your healthcare provider right away. Some signs of allergic reaction may include shortness of breath, rash, itching, redness of the skin, and fainting/dizziness.
  • People with Factor VII deficiency should be monitored by their healthcare provider for antibodies, which can cause NovoSeven® RT to stop working properly.

Side Effects

  • The most common and serious side effects are blood clots.
  • Tell your healthcare provider about any side effects that bother you or do not go away.

Use with Other Drugs

  • Blood clots may occur if NovoSeven® RT is given with Coagulation Factor XIII (13).

Please click here for Prescribing Information.

NovoSeven® RT is a prescription medication.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.